<?xml version="1.0" encoding="UTF-8"?>
<p>The valued benefit of screening for HBV infection prior commencing immunosuppressive treatment has been established in several medical society guidelines. Increasing physician awareness for the risk of HBVr has improved clinical outcomes in the past,
 <sup>
  <xref rid="bibr108-1759720X20912646" ref-type="bibr">108</xref>
 </sup> whereas, with appropriate screening, up to 80% of HBVr could be preventable.
 <sup>
  <xref rid="bibr45-1759720X20912646" ref-type="bibr">45</xref>
 </sup>
</p>
